Total Payments
$2,207
2024 Payments
$387.43
Companies
7
Transactions
20
Payment Breakdown by Category
Food & Beverage$1,222 (55.4%)
Travel$985.54 (44.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,222 | 16 | 55.4% |
| Travel and Lodging | $985.54 | 4 | 44.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,058 | 7 | $0 (2018) |
| CSL Behring | $493.06 | 6 | $0 (2024) |
| HEMA Biologics, LLC | $439.23 | 3 | $0 (2024) |
| Octapharma USA, Inc. | $106.90 | 1 | $0 (2021) |
| Osiris Therapeutics Inc. | $43.24 | 1 | $0 (2018) |
| Cerus Corporation | $34.02 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $32.82 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $387.43 | 5 | CSL Behring ($358.42) |
| 2023 | $577.68 | 5 | HEMA Biologics, LLC ($410.22) |
| 2021 | $106.90 | 1 | Octapharma USA, Inc. ($106.90) |
| 2018 | $1,135 | 9 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($1,058) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $34.27 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/18/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 08/14/2024 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: Hematology | ||||||
| 06/18/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $165.80 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 05/09/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $33.35 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/28/2023 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $205.11 | General |
| Category: Hematology | ||||||
| 09/28/2023 | HEMA Biologics, LLC | SevenFact (Biological) | Food and Beverage | In-kind items and services | $205.11 | General |
| Category: Hematology | ||||||
| 06/22/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: Oncology | ||||||
| 04/27/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/28/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $103.95 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 08/24/2021 | Octapharma USA, Inc. | OCTAPLAS (Biological) | Food and Beverage | In-kind items and services | $106.90 | General |
| Category: INTENSIVE CAREEMERGENCY | ||||||
| 11/14/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Travel and Lodging | Cash or cash equivalent | $668.40 | General |
| 11/14/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Travel and Lodging | Cash or cash equivalent | $227.36 | General |
| 11/14/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | Cash or cash equivalent | $55.12 | General |
| 11/14/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Travel and Lodging | Cash or cash equivalent | $48.00 | General |
| 11/14/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Travel and Lodging | Cash or cash equivalent | $41.78 | General |
| 11/14/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.74 | General |
| 11/14/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | Cash or cash equivalent | $3.68 | General |
| 10/18/2018 | Cerus Corporation | — | Food and Beverage | Cash or cash equivalent | $34.02 | General |
| Category: DEVICE-TRANSFUSION | ||||||
| 03/07/2018 | Osiris Therapeutics Inc. | GRAFIX/GRAFIXPL/STRAVIX (Biological) | Food and Beverage | Cash or cash equivalent | $43.24 | General |
| Category: WOUND CARE | ||||||
About Dr. Martin Bluth, M.D
Dr. Martin Bluth, M.D is a Clinical Pathology healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053586701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Bluth, M.D has received a total of $2,207 in payments from pharmaceutical and medical device companies, with $387.43 received in 2024. These payments were reported across 20 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,222).
Ad
Practice Information
- Specialty Clinical Pathology
- Other Specialties Blood Banking & Transfusion Medicine
- Location Detroit, MI
- Active Since 04/24/2008
- Last Updated 10/22/2015
- Taxonomy Code 207ZC0006X
- Entity Type Individual
- NPI Number 1053586701
Products in Payments
- Kcentra (Biological) $493.06
- SevenFact (Biological) $439.23
- OCTAPLAS (Biological) $106.90
- GRAFIX/GRAFIXPL/STRAVIX (Biological) $43.24
- DARZALEX (Biological) $32.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.